AHIP Member Plan employees can log in to view additional content.
Issues
High-Price Drugs
Our Position
Everyone should be able to get the medications they need at a cost they can afford. But drug prices are out of control, and hardworking families feel the consequences every day. It’s time to hold Big Pharma accountable for the prices that they, and they alone, set and increase year after year.
Health insurance providers fight against Big Pharma’s price gouging for more affordable medications for Americans. We do not have to choose between innovation and affordability. With the right solutions, Americans can have both.
At a Glance
-
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Puerto Rico
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Contacts Refined by Maryland
View State PageMaryland State Affairs & Policy Staff
- Jacqueline Bell
- Legislative/Regulatory Analyst
- 202-778-3222
- jbell@ahip.org
- Kris Hathaway
- Executive Director
Resources
Policy • 04.04.2022
Amicus Brief Pfizer v. HHS
PDF Included
Research • 02.16.2022
Research • 12.14.2021
State Law Chart • 09.15.2021
Policy • 08.16.2021
Interchangeable Biosimilars Offer Great Promise for Affordable Life-Saving Drugs
PDF Included • 1 Page
Comment Letter • 08.11.2021
Related Events
Webinar
Crossing the Chasm with an Integrated Core Administrative Ecosystem Across Medical and Pharmacy
- Date:
- Jun 2, 2022 • 1:00 – 2:00 pm EDT
Webinar
Closing Health Equity Gaps in Well-Being by Addressing Financial Health
- Date:
- Jun 14, 2022 • 1:00 – 2:00 pm EDT